Advertisement
Home 2018 November

Monthly Archives: November 2018

The U.S. Food and Drug Administration recently announced the approval of Daurismo (glasdegib) tablets for use in combination with a low dose of the chemotherapy cytarabine to treat newly diagnosed acute myeloid leukemia. The treatment is indicated for patients aged 75 years or older who have comorbidities that may prevent the use of intensive chemotherapy.

FDA Approves New Treatment for Acute Myeloid Leukemia

0
Randomized clinical trial showed significant improvement in overall survival with Daurismo
Ebola infections in newborns are being reported in the current outbreak of the deadly disease in Congo

Newborns Infected With Ebola in Congo Outbreak

0
Seven cases seen in newborn babies and infants younger than 2 years old
The prevalence of parent-reported autism spectrum disorder is estimated at 2.5 percent among U.S. children aged 3 to 17 years

Estimated 2.5 Percent of U.S. Children Diagnosed With Autism

0
Children with parent-reported ASD have greater health care needs, difficulty accessing care
Millions of workers gained insurance coverage under the Affordable Care Act without adverse effects on labor markets

ACA Coverage Substantial, but Did Not Impact Labor Markets

0
Coverage gains did not negatively impact employment levels, hours worked, earnings
Antibiotic use in children <24 months of age is associated with a slightly higher body weight at 5 years of age

Early Antibiotic Use May Be Tied to Higher Childhood Body Weight

0
Antibiotics before age 2 associated with very small increase in body weight at 5 years of age
The U.S. Preventive Services Task Force (USPSTF) recommends HIV screening for individuals aged 15 to 65 years

USPSTF Suggests Universal HIV Screening, PrEP for High-Risk Patients

0
Screening recommended for those ages 15 to 65 years, including pregnant women
In 2015

CDC: U.S. Prevalence of ALS Was 5.2 Per 100,000 in 2015

0
Total of 16,583 cases identified in 2015 using National Amyotrophic Lateral Sclerosis Registry
From 2018 to 2030

Insulin Needed for T2DM Tx Set to Increase >20 Percent by 2030

0
Using higher HbA1c target in over-75s could increase disability-adjusted life-years by 44.2 percent
For patients with primary progressive multiple sclerosis

Ocrelizumab May Help Preserve Hand, Arm Function in PPMS

0
Ocrelizumab reduces risk for more severe progression
For children with acute gastroenteritis

Probiotics Show No Benefits for Pediatric Acute Gastroenteritis

0
No benefits seen with Lactobacillus rhamnosus GG or L. rhamnosus R0011 and L. helveticus R0052